 TORONTO, Aug. 31, 2021 GLOBE NEWSWIRE -- Field Trip Health Ltd. TSX: FTRP; FTRP.WT; Nasdaq: FTRP Field Trip, a leader in the development and delivery of psychedelic therapies, is pleased to announce the launch of KAP Co-op, a program that enables eligible independent psychedelic therapists to provide ketamine-assisted psychotherapy and, in the future, other legal, psychedelic-assisted therapies at its Field Trip Health centers. Field Trip is also pleased to announce the launch of training programs designed to provide interested psychotherapists or other qualified mental health professionals and clinicians with access to best-in-class training on KAP. 